True North Advisors LLC Buys 930 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

True North Advisors LLC lifted its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 11.9% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 8,756 shares of the company’s stock after buying an additional 930 shares during the quarter. True North Advisors LLC’s holdings in U.S. Physical Therapy were worth $777,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. BNP Paribas Financial Markets grew its holdings in shares of U.S. Physical Therapy by 283.0% during the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock worth $1,425,000 after purchasing an additional 12,445 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in U.S. Physical Therapy by 57.1% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock valued at $223,000 after acquiring an additional 956 shares in the last quarter. State Street Corp raised its stake in shares of U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company’s stock worth $56,522,000 after acquiring an additional 99,244 shares during the last quarter. Stifel Financial Corp lifted its position in shares of U.S. Physical Therapy by 12.1% during the third quarter. Stifel Financial Corp now owns 57,166 shares of the company’s stock worth $4,838,000 after purchasing an additional 6,154 shares in the last quarter. Finally, Harbor Capital Advisors Inc. grew its stake in shares of U.S. Physical Therapy by 113.4% during the third quarter. Harbor Capital Advisors Inc. now owns 16,188 shares of the company’s stock valued at $1,370,000 after purchasing an additional 8,604 shares during the last quarter.

Insider Buying and Selling

In related news, Director Bernard A. Harris, Jr. sold 2,000 shares of U.S. Physical Therapy stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total transaction of $185,900.00. Following the completion of the transaction, the director now owns 16,726 shares in the company, valued at approximately $1,554,681.70. This trade represents a 10.68 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Carey P. Hendrickson sold 516 shares of the stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the transaction, the chief financial officer now directly owns 20,469 shares in the company, valued at $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 7,412 shares of company stock valued at $706,605. 1.70% of the stock is owned by corporate insiders.

U.S. Physical Therapy Stock Up 0.4 %

NYSE:USPH opened at $90.47 on Thursday. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63. The stock has a 50-day moving average price of $92.48 and a two-hundred day moving average price of $88.86. The stock has a market cap of $1.37 billion, a price-to-earnings ratio of 96.24, a PEG ratio of 3.71 and a beta of 1.48. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 15th were paid a dividend of $0.44 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a yield of 1.95%. U.S. Physical Therapy’s payout ratio is 187.23%.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Barrington Research reaffirmed an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a report on Thursday, November 21st. JPMorgan Chase & Co. raised their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. JMP Securities began coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price for the company. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. Finally, Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price objective for the company from $100.00 to $115.00 in a report on Monday, December 16th. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, U.S. Physical Therapy currently has an average rating of “Buy” and a consensus price target of $114.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.